| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 75,588 | 62,080 | | Cost of Revenue | 19,252 | 17,944 | | | Gross Profit | 56,336 | 44,135 | | | Operating Expenses | | Research Development | 20,309 | 16,837 | | Selling General and Administrative | 22,094 | 16,293 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 13,933 | 11,006 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,112 | 1,623 | | Earnings Before Interest And Taxes | 15,045 | 12,629 | | Interest Expense |
-
| 869 | | Income Before Tax | 15,045 | 11,760 | | Income Tax Expense | 4,288 | 1,243 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 10,757 | 10,517 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 10,757 | 10,517 | | Preferred Stock And Other Adjustments |
-
| (82) | | | Net Income Applicable To Common Shares | $10,757 | $10,435 |
|
1.48% Nasdaq 
Income Statement
